Financials
- Market Capitalization 12.78 B
- Employee 839
- Founded 2015
- CEO Neil Kumar
- Website www.bridgebio.com
- Headquarter Delaware, United States
- FIGI BBG00P9KDZK6
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-20.24
市销率
29.18
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 711 | SMMT Summit Therapeutics Inc. - Common Stock | 17.59 USD | +2.45% | +3.65% | -2.66% | -11.43% | 14.03 B USD | ||
| 745 | CORT Corcept Therapeutics Incorporated - Common Stock | 121.19 USD | +2.24% | +4.84% | +6.89% | +65.18% | 13.10 B USD | ||
| 774 | HALO Halozyme Therapeutics, Inc. - Common Stock | 110.42 USD | +0.53% | +0.70% | +2.24% | +65.30% | 12.53 B USD | ||
| 829 | TECH Bio-Techne Corp - Common Stock | 72.46 USD | +0.01% | +0.07% | +0.35% | +22.09% | 11.36 B USD |